FIELD: medicine; endocrinology; immunology.
SUBSTANCE: present group of inventions refers to using a combination of kynurenin and antigen-representing fibroblast cells for treating an autoimmune disease.
EFFECT: introduction of the combination provides effective treatment of such autoimmune diseases as type 1 diabetes or alopecia areata due to synergetic immunomodulatory action of the components of the combination.
33 cl, 2 ex, 2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF T-CELL ACTIVATION | 2012 |
|
RU2657440C2 |
| METHODS AND COMPOSITIONS FOR USE IN CELL THERAPY | 2010 |
|
RU2610427C2 |
| COMPOSITION FOR PREVENTIVE OR THERAPEUTIC TREATMENT OF CONDITIONS ASSOCIATED WITH CHANGING AMOUNT OF HAIR | 2018 |
|
RU2716159C2 |
| CARBOHYDRATE-MODIFIED PARTICLES AND POWDERED COMPOSITIONS FOR IMMUNE RESPONSE MODULATION | 2016 |
|
RU2752620C2 |
| METHODS AND COMPOSITIONS FOR STABLE IMMUNOTHERAPY | 2014 |
|
RU2696876C2 |
| MEDICINAL PRODUCTS BASED ON LANTHIONINE SYNTHETASE C-LIKE 2 PROTEIN | 2020 |
|
RU2768888C1 |
| PEPTIDES AND DIABETES TREATMENT METHODS | 2018 |
|
RU2761653C2 |
| MEDICINES BASED ON LANTIONINE SYNTHETASE OF C-LIKE PROTEIN 2 | 2015 |
|
RU2741576C2 |
| GENETICALLY MODIFIED BACTERIA STABLY EXPRESSING IL-10 AND INSULIN | 2017 |
|
RU2768027C2 |
| CELLS EXPRESSING PARATHYROID HORMONE 1 RECEPTOR, AND THEIR USE | 2017 |
|
RU2771328C2 |
